BioSpace News Archive

Policy

Political Battle Over Fetal Tissue Could Force Closure of Research Center Pivotal to HIV Therapies

Researchers who focus on HIV vaccines are caught in the middle of a political battle over funding of fetal stem cell research.

December 5, 2018
·
3 min read
·
Alex Keown
Policy

Vitruvias Therapeutics Inc., Licenses Potassium Chloride ER ANDA (10 and 20 mEq) Capsules to Be Manufactured at Bora Pharmaceutical’s New Zhunan Facility in Taiwan

Vitruvias Therapeutics Inc. has agreed to license an approved Potassium Chloride Extended release ANDA.

December 5, 2018
·
2 min read
Business

Helping the Missing Million

More than one million Canadians are estimated to be living with COPD and don’t know it

December 5, 2018
·
3 min read
Biotech Bay

Protagonist Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

Protagonist Therapeutics, Inc. today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will provide a corporate overview at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference in New York.

December 5, 2018
·
1 min read
Medicenna Receives US$1.2 Million Non-Dilutive Grant Payment

Medicenna Therapeutics Corp. announced today that it has received US$1,224,540 (approximately, CD$1.6M) from the Cancer Prevention and Research Institute of Texas (“CPRIT”).

December 5, 2018
·
1 min read
Pharm Country

Therap Announces 2019 National Conference Keynote Speakers

Presenters to Speak on Best Practices, Implementation Strategies, and Recommendations on Meeting State Regulations

December 5, 2018
·
2 min read
Business

Breathe Life Healing Center Announces Strategic Alliance with Experience Recovery

Breathe Life Healing Center announced today a strategic alliance with Experience Recovery, an in-network sub-acute ambulatory detox facility providing all care levels.

December 5, 2018
·
2 min read
Drug Development

Daiichi Sankyo Presents Updated Phase 1 Data for U3-1402 in Patients with HER3-Expressing Metastatic Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS)

Updated efficacy and safety results presented from ongoing phase 1/2 study with U3-1402, an investigational and potential first-in-class HER3-targeting antibody drug conjugate (ADC), in patients with heavily pretreated HER3-positive metastatic breast cancer

December 5, 2018
·
7 min read
BioCapital

Municipal Wastewater Holds The Key To Tracking Opioid Intervention Initiatives

In 2016, opioids were the primary cause of more than 42,000 deaths in the U.S. Controlled substances (opioids and other drugs, such as marijuana) pose a threat to both human and environmental health.

December 5, 2018
·
3 min read
Pharm Country

iCell Gene Therapeutics Presents First-in-Human Data of CLL1-CD33 Compound CAR T in Refractory Acute Myeloid Leukemia

CLL1-CD33 Compound CAR (cCAR) demonstrates consistent, specific, and potent anti-tumor activity in vitro and in vivo

December 5, 2018
·
3 min read